Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

Civeira, Fernando·2004·Atherosclerosis
DOI 10.1016/j.atherosclerosis.2003.11.010

Cited by (496)

Items 301–400 of 496

  1. Clinical and biochemical features of atherogenic hyperlipidemias with different genetic basis: A comprehensive comparative study
    А. В. Блохина, Alexandra I. Ershova, Anna V. Kiseleva, Е. А. Сотникова, Anastasia A. Zharikova, Marija Zaicenoka, Yuri V. Vyatkin, Vasily E. Ramensky, Vladimir Aleksandrovich Kutsenko, Olga A. Litinskaya et al. · 2024 · PLoS ONE
  2. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
    Sinan Üy, Sansoy · 2014 · PubMed
  3. Polygenic Markers in Patients Diagnosed of Autosomal Dominant Hypercholesterolemia in Catalonia: Distribution of Weighted LDL-c-Raising SNP Scores and Refinement of Variant Selection
    Jesús María Martín-Campos, Sheila Ruiz‐Nogales, Daiana Ibarretxe, Emilio Ortega, Elisabet Sánchez-Pujol, Meritxell Royuela, Àlex Vila, Carolina Guerrero, Alberto Zamora, Cristina Soler i Ferrer et al. · 2020 · Biomedicines
  4. Dyslipidemia: Current Therapies and Strategies to Overcome Barriers for Use
    Catherine DePhillips, Puja B. Parikh, Gregg Stevens · 2021 · The Journal for Nurse Practitioners
  5. Evaluation of the Effectiveness of Individually Tailored Lifestyle Intervention in Patients With Familial Hypercholesterolemia
    Seçil Beyece İncazlı, Serap Özer, Meral Kayıkçıoğlu · 2022 · The Journal of Cardiovascular Nursing
  6. La lipoproteína(a) se asocia a la presencia de arteriosclerosis en pacientes con hipercolesterolemia primaria
    Ana M. Bea, Rocío Mateo‐Gállego, Estíbaliz Jarauta, Rosa Villa-Pobo, Pilar Calmarza, Itziar Lamíquiz-Moneo, Ana Cenarro, Fernando Civeira · 2014 · Clínica e Investigación en Arteriosclerosis
  7. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia
    Anouk van der Graaf, Barbara A. Hutten, John J.P. Kastelein, Maud N. Vissers · 2006 · Expert Review of Cardiovascular Therapy
  8. Cross-Over Trial of Intensive Monotherapy With Atorvastatin and Combined Therapy With Atorvastatin and Colestimide for Japanese Familial Hypercholesterolemia
    Hiromi Tasaki, Masaharu Miyamoto, Takahiro Kubara, Fumihiko Kamezaki, Seiya Tanaka, Kazuhito Yamashita, Masato Tsutsui, Yasuhide Nakashima · 2005 · Circulation Journal
  9. Targeting High-Risk Young Patients for Statin Therapy
    Antonio M. Gotto · 2004 · JAMA
  10. 14. Familial hypercholesterolemia
    Lyudmila Vladimirova‐Kitova, S. Kitov · 2016 · Wageningen Academic Publishers eBooks
  11. Short-term Follow-up Results of Drug-eluting Stenting in Premature Coronary Artery Disease Patients with Multiple Atherosclerotic Risk Factors
    Ming-Hsiung Wang, Wen-Lieng Lee, Kuo‐Yang Wang, Yu‐Cheng Hsieh, Tsun-Jui Liu, I-Hsiang Lin, Wei-Wen Lin, Chih-Tai Ting, Kae‐Woei Liang · 2008 · Journal of the Chinese Medical Association
  12. Tratamiento de la hipercolesterolemia familiar heterocigota en la infancia y la adolescencia: un problema no resuelto
    Fernando Civeira, Núria Plana · 2017 · Revista Española de Cardiología
  13. Demographic profile, clinical characteristics and medical management patterns of Indian coronary artery disease patients: a nationwide urban-based, real-world, retrospective, observational electronic medical record study– report of baseline data
    Mohammed Yunus Khan, Sucheta Pandit, Santanu Guha, Uday Jadhav, M. Srinivas Rao, Kumar Gaurav, Amey Mane, Akhilesh Dubey, Hitendra M. Bhagwatkar, Keshavamurthy Venkataswamy et al. · 2021 · Expert Review of Cardiovascular Therapy
  14. Current causes of death in familial hypercholesterolemia
    Victoria Marco-Benedí, Ana M. Bea, Ana Cenarro, Estíbaliz Jarauta, Martín Laclaustra, Fernando Civeira · 2022 · Lipids in Health and Disease
  15. A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels
    Maria K Eriksson Svensson, Stefan Karl James, Annica Ravn‐Fischer, Guillermo Villa, Lovisa Schalin, Thomas Cars, Stefan Gustafsson, Emil Hagström · 2024 · Upsala Journal of Medical Sciences
  16. Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry
    Lοukianos S. Rallidis, Christos V. Rizos, Konstantinos A. Papathanasiou, George L. Liamis, Ioannis Skoumas, Anastasia Garoufi, Genovefa D. Kolovou, Κωνσταντίνος Τζιόμαλος, Emmanouil I. Skalidis, Vasilios Kotsis et al. · 2024 · Journal of Cardiovascular Medicine
  17. Valvular and Supravalvular Aortic Stenosis in Heterozygous Familial Hypercholesterolemia, A Case Report
    Kiyoshi Ozumi, Hiromi Tasaki, Kazuhiko Yamashita, Seiya Tanaka, Takakazu Sasaguri, Yasuyuki Sasaguri, Yasuhide Nakashima · 2005 · Journal of Atherosclerosis and Thrombosis
  18. The fine line between familial and polygenic hypercholesterolemia
    Isabel de Castro-Orós, Miguel Pocovı́, Fernando Civeira · 2013 · Clinical Lipidology
  19. The Draupadi of dyslipidemia: Familial hypercholesterolemia
    Sanjay Kalra, JPS Sawhney, Rakesh Kumar Sahay · 2016 · Indian Journal of Endocrinology and Metabolism
  20. Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice
    Marc Steven Sabatine, James A. Underberg, Michael J. Koren, Seth J. Baum · 2016 · Postgraduate Medicine
  21. Homozygous familial hypercholesterolemia.
    M.K. Alicezah, Rafezah Razali, Thuhairah Hasrah Abdul Rahman, Hoh Bp, Nur Suhana Hamzan, Suhaila Abd Muid, Nawawi Hm, M Koshy · 2014 · PubMed
  22. Effect of LDL-apheresis on plasma lipids, chitotriosidase and anti-oxLDL antibodies in heterozygous familial hypercholes-terolemia
    Maria Musumeci, Francesco Pappalardo, GianCarlo Tonolo, Fernando Torrisi, Francesca Gullo, Salvatore Musumeci · 2009 · Journal of Biomedical Science and Engineering
  23. Hypercholesterolemia in children and young adults—current management
    Frederick Johan Raal · 2009 · Journal of Endocrinology Metabolism and Diabetes of South Africa
  24. Prevalence of genetically diagnosed familial hypercholesterolemia in Vietnamese patients with premature acute myocardial infarction
    Kha Minh Nguyen, Sy Van Hoang · 2024 · Medicine
  25. First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias
    Claudia Stefanutti, Giovanna D’Alessandri, Adrián Petta, Mariko Harada‐Shiba, Ulrich Julius, Handrean Soran, Patrick M. Moriarty, Stefano Romeo, Euridiki Drogari, Beate Roxane Jaeger · 2015 · Atherosclerosis Supplements
  26. The Lipid Hypothesis and the Seven Countries Study
    Ronan Lordan, Αλέξανδρος Τσούπρας, Ioannis Zabetakis · 2019 · Elsevier eBooks
  27. Phenotypic vs. genetic cascade screening for familial hypercholesterolemia: A case report
    А. В. Блохина, Alexandra I. Ershova, Alexey N. Meshkov, Anna V. Kiseleva, М. В. Климушина, Anastasia A. Zharikova, Е. А. Сотникова, Vasily E. Ramensky, Oxana M. Drapkina · 2022 · Frontiers in Cardiovascular Medicine
  28. Extremely high-risk patients with acute coronary syndrome: How “extreme” should lipid-lowering therapy be if the LDL-C target <40 mg/dl is considered?
    Lοukianos S. Rallidis, Donatos Tsamoulis, Ioannis Leventis, Petros Kalogeras, Iosif Delakis, Elefterios Samiotis, Charalampos Kalantzis, Belkis Malkots, Dimitrios Tasoulas, Vasileios Bouratzis et al. · 2023 · Kardiologia Polska
  29. Gene Mutation in Patients with Familial Hypercholesterolemia and Response to Alirocumab Treatment—A Single-Centre Analysis
    Joanna K. Rogozik, Jakub Kosma Rokicki, Marcin Grabowski, Renata Główczyńska · 2024 · Journal of Clinical Medicine
  30. The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E
    Dagmar Solichová, Milan BL Aacute HA, Jana Aufartová, Lenka Kujovská Krčmová, Jir iacute PL Iacute Scaron EK, Barbora Honegrova, Eva Kasalová, Miriam Lánská, Lubor Urbánek, Lubos Sobotka · 2015 · Journal of Nutritional Science and Vitaminology
  31. Statin restores cardiac autonomic response to acute hypoxia in hypercholesterolaemia
    Maria S. Brasileiro‐Santos, José Augusto Soares Barreto-Filho, Raul Dias Santos, Ana Paula Marte Chacra, Carine Teles Sangaleti, Gisele Alvez, Otavio Coelho Bezerra, Luiz Aparecido Bortolotto, Maria Cláudia Irigoyen, Fernanda Marciano Consolim‐Colombo · 2013 · European Journal of Clinical Investigation
  32. Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia: A One Center Study
    Vana Kolovou, Niki Katsiki, Stamatis S. Makrygiannis, Sophie Mavrogieni, Nikoletta Karampetsou, Athanasios John Manolis, Andreas J. Melidonis, Dimitri P. Mikhailidis, Genovefa D. Kolovou · 2020 · Journal of Cardiovascular Pharmacology and Therapeutics
  33. Awareness, treatment rates, and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable, or definite familial hypercholesterolemia
    Samet Yaman, Didem Özdemir, Büşra Tuğçe Akman, Bekir Çakır, Osman Ersoy · 2020 · Postgraduate Medicine
  34. A retrospective study of people with familial hypercholesterolaemia in a Belgian lipid clinic
    Veerle Ide, Diederik De Cock, Sofia Pazmiño, Roman Vangoitsenhoven, Bart Van der Schueren, Ann C. Mertens · 2023 · Acta cardiologica. Supplementum
  35. Treatment of Heterozygous Familial Hypercholesterolemia in Children and Adolescents: An Unsolved Problem
    Fernando Civeira, Núria Plana · 2017 · Revista Española de Cardiología (English Edition)
  36. Familial hypercholesterolemia in childhood and adolescents: A hidden reality
    Núria Plana, Cèlia Rodríguez-Borjabad, Daiana Ibarretxe, L. Masana · 2017 · Clínica e Investigación en Arteriosclerosis (English Edition)
  37. Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience
    Paola Sabrina Buonuomo, Marina Macchiaiolo, Giovanna Leone, Paola Valente, Gerarda Mastrogiorgio, Maria Gnazzo, Ippolita Rana, Michaela Veronika Gonfiantini, Maria Giulia Gagliardi, Francesca Romano et al. · 2018 · European Journal of Preventive Cardiology
  38. Clinical and Genetic Characteristics of Familial Hypercholesterolemia at Sultan Qaboos University Hospital in Oman
    Khalid Al-Waili, Khalid Al‐Rasadi, Fahad Zadjali, Khamis Al-Hashmi, Suad Al-Mukhaini, Mohammed Al-Kindi, Hilal Ali Al-Sabti, Ali Talib Al-Hinai, Hatem Farhan, Ibrahim S Al-Zakwani · 2020 · Oman Medical Journal
  39. Rendimiento diagnóstico de la secuenciación de genes de hipercolesterolemia familiar en sujetos con hipercolesterolemia primaria
    Itziar Lamíquiz-Moneo, Fernando Civeira, Rocío Mateo‐Gállego, Martín Laclaustra, Belén Moreno‐Franco, María Teresa Tejedor, Lourdes Palacios, César Martı́n, Ana Cenarro · 2020 · Revista Española de Cardiología
  40. Genetics of Cardiovascular Diseases
    Silvia Giuliana Priori, Carlo Napolitano, Steve Eric Humphries, James R. A. Skipworth · 2009
  41. Long-term effects of the cholesterol level and its drug treatment
    Laura Hyttinen · 2011
  42. Exome Sequencing Enhances Screening for Familial Hypercholesterolemia Within a Multi-Site Healthcare System
    Niloy Jewel Samadder, Mariah L. Schroeder, Molly M. Voss, Fadi Elias Shamoun, Iftikhar J. Kullo, Timothy B. Curry, Elisa J. F. Houwink, Michelle L. Bublitz, Lorelei A. Bandel, Sebastian M. Armasu et al. · 2025 · Circulation Genomic and Precision Medicine
  43. Carotid sheath xanthoma: A rare manifestation of lipid disorders
    Binyang Gao, Yan Qing Luo, Ying He, Jing Huang, Xiaorong Wen · 2021 · Journal of clinical lipidology
  44. Developing a Hybrid Risk Assessment Tool for Familial Hypercholesterolemia: A Machine Learning Study of Chinese Arteriosclerotic Cardiovascular Disease Patients
    Lei Wang, Jian Hong Guo, Zhuang Tian, Samuel Seery, Jin Ye, Shuyang Zhang · 2022 · Frontiers in Cardiovascular Medicine
  45. Impact of conducting a genetic study on the management of familial hypercholesterolemia
    Victoria Marco-Benedí, Ana Cenarro, Àlex Vila, José Tomás Real, Juan José Tamarit, José Luis Álvarez-Sala, José Luis Díaz-Díaz, Verónica Perea, Fernando Civeira, Antonio J. Vallejo‐Vaz · 2023 · Journal of clinical lipidology
  46. Hypercholesterolaemic valvulopathy in a young woman with heterozygous familial hypercholesterolaemia
    Kunal Mahajan, Sanjeev Asotra, Prakash Chand Negi · 2016 · BMJ Case Reports
  47. Statin therapy and lipids-lowering supplements – safe and effective treatment of lipids disturbances in children
    Małgorzata Grabarczyk, Kinga Pomianowska, Tymoteusz Zaręba-Głód, Agnieszka Zachurzok, Ewa Małecka‐Tendera, Paweł Matusik · 2022 · Pediatric Endocrinology Diabetes and Metabolism
  48. Factors associated with the presence of tendon xanthomas in familial hypercholesterolemia
    Pablo Manuel Fernández Corredoira, Victoria Marco-Benedí, Ana Cenarro, Sonia Peribáñez Belanche, Salvador Carrión Olmos, Fernando Civeira · 2024 · Revista Española de Cardiología (English Edition)
  49. Alteraciones del metabolismo de las lipoproteínas
    Juan Pedro-Botet Montoya, Luis Masana Marín, Rafael Carmena Rodríguez · 2014 · Elsevier eBooks
  50. Real-time spatial compound sonography of Achilles tendon in patients with heterozygous familial hypercholesterolaemia and normal physical examination
    Tommaso Vincenzo Bartolotta, Adele Taibbi, G. Malizia, Giuseppe Mamone, Carlo Maria Barbagallo, Massimo Midiri, Roberto Lagalla · 2007 · La radiologia medica
  51. Diagnóstico y tratamiento de las hiperlipemias familiares
    Teresa Mantilla Morató, Rodrigo Alonso K, P. Mata · 2004 · Atención Primaria
  52. Guías de práctica clínica de manejo de la dislipemia en diabéticos y otros grupos de riesgo
    Marta Fanlo‐Maresma, Xavier Pintó · 2015 · Revista Española de Cardiología Suplementos
  53. Familial hypercholesterolemia associated with severe hypoalphalipoproteinemia in a Moroccan family
    Karima Aït Chihab, Rachid Chater, Ana Cenarro, Anass Kettani, Sergio Castillo, Mohamed Loutfi, Josep Ribalta, A. Adlouni, Miguel Pocovı́, Mariame El Messal · 2007 · Journal of Genetics
  54. Familial Hypercholesterolemia: A Call for Increased Awareness in the Asian Indian Population
    Sophia Wong, Akhil Garg · 2014
  55. Molecular screening of familial hypercholesterolemia in Icelanders
    Greg Kellogg, Bolli Þórsson, Ying Cai, Robert G. Wisotzkey, Andrew Pollock, Matthew Akana, Rebecca Fox, Michael Jansen, Elias Freyr Gudmundsson, Bonny Patel et al. · 2020 · Scandinavian Journal of Clinical and Laboratory Investigation
  56. NHG-Standpunt Diagnostiek en behandeling van familiaire hypercholesterolemie
    Edmond Walma, Tj Wiersma · 2011 · Bohn Stafleu van Loghum eBooks
  57. Genetic Factors of Cardiovascular Diseases
    Fernando Civeira, Delia Recalde, A.L. García-Otín, Ana Cenarro · 2008 · Elsevier eBooks
  58. A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients
    Anne Carol Goldberg, Richard L. Dunbar, Linda Hemphill, Stephan P. Babirak, Gerald Wilson, Michael Wooten, Mohamed Iydroose, Kelley C. Dacus, Heather Minchew, J Dutton et al. · 2020 · Journal of clinical lipidology
  59. Effects of LDLR variants rs5928, rs750518671 and rs879254797 on protein structure and functional activity in HepG2 cells transfected with CRISPR/Cas9 constructs
    Augusto Akira Mori, Vanessa Barbosa Malaquias, Kennedy Bonjour, Gláucio Monteiro Ferreira, Raul Hernandes Bortolin, Jéssica Bassani Borges, Victor Fernandes de Oliveira, Rodrigo Marques Gonçalves, André Árpád Faludi, Gisele Medeiros Bastos et al. · 2023 · Gene
  60. Dysfunctional co-expression network analysis of familial hypercholesterolemia
    Yizhou Ye, Kefei Li, Jian Liu, Mingqiu Li, Wei Wang, Ruxing Wang, Jian Zou, Ping Xie, Liuyan Wei, Guoqing Jiao et al. · 2013 · Journal of Cardiology
  61. Familial Hypercholesterolemia in Iran: A Novel Frameshift Mutation in Low Density Lipoprotein Receptor (LDLR) Gene
    Pezhman Fard‐Esfahani, Shohreh Khatami · 2010 · Iranian journal of pathology
  62. PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center
    А. В. Блохина, Alexandra I. Ershova, Alena S. Limonova, Копылова Оксана Викторовна, Alexey N. Meshkov, Oksana M. Drapkina · 2022 · Rational Pharmacotherapy in Cardiology
  63. Implementation science and genetic testing for familial hypercholesterolemia
    Karen L. Birkenhead, DAVID R. SULLIVAN, Gerald Francis Watts, Mitchell Sarkies · 2024 · Current Opinion in Lipidology
  64. Low-Density Lipoprotein (LDL) Apheresis
    Paul Barton Duell · 2015 · Contemporary Endocrinology
  65. Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Christopher Carroll, Paul Tappenden, Rachid Rafia, Jean Hamilton, Duncan Chambers, Mark Clowes, Paul N. Durrington, Nadeem Qureshi, Anthony S. Wierzbicki · 2016 · PharmacoEconomics
  66. NICE Guidance on Familial Hypercholesterolaemia: All Sugar and Spice?
    Gerald Francis Watts, Ian R Hamilton‐Craig, DAVID R. SULLIVAN · 2009 · Heart Lung and Circulation
  67. Approaches to dyslipidemia treatment in children and adolescents
    Lorenzo Iughetti, Barbara Predieri, Patrizia Bruzzi, Fiorella Balli · 2008 · Expert Review of Endocrinology & Metabolism
  68. LDL apheresis for familial hypercholesterolemia: value, indications and demand
    Gerald Francis Watts, Sandra J. Hamilton · 2009 · Clinical Lipidology
  69. Imaging biomarkers to track subclinical atherosclerosis in heterozygous familial hypercholesterolemia
    Marcio Hiroshi Miname, Raul Dias Santos · 2013 · Clinical Lipidology
  70. Single step PCR for the identification of Low Density Lipoprotein Receptor (LDL-R) gene mutations
    Samia Perwaiz Khan, Rubina Ghani, Zia Yaqub · 2014 · Pakistan Journal of Medical Sciences
  71. Atherosclerosis progression in patients with autosomal dominant hypercholesterolemia in clinical practice
    Estíbaliz Jarauta, Rocío Mateo‐Gállego, Ana M. Bea, Manuel Crespo, Alba Ballester, María Victoria Rubio Rubio, Lucía Baila-Rueda, Pilar Calmarza, Ana Cenarro, Eric de Groot et al. · 2014 · Journal of clinical lipidology
  72. Papel de los lípidos en la ateroesclerosis
    Fernando Civeira, Victoria Marco-Benedí, Ana Cenarro · 2020 · Revista Española de Cardiología Suplementos
  73. Kolaviron, A Biflavonoid Compound: Its Pharmacological Activity and Therapeutic Efficacy
    Oluwafemi Adeleke Ojo, Damilare Emmanuel Rotimi, Jennifer Chidubem Amanze, Adebola Busola Ojo, Matthew Eboseremen Iyobhebhe, Tobiloba Christiana Elebiyo · 2021 · Current Bioactive Compounds
  74. Factores asociados a la presencia de xantomas tendinosos en la hipercolesterolemia familiar
    Pablo Manuel Fernández Corredoira, Victoria Marco-Benedí, Ana Cenarro, Sonia Peribáñez Belanche, Salvador Carrión Olmos, Fernando Civeira · 2024 · Revista Española de Cardiología
  75. Hipercolesterolemia familiar. Criterios diagnósticos y tratamientos actuales
    Esperanza Aguillo Gutiérrez · 2005 · Endocrinología y Nutrición
  76. The management of familial hypercholesterolaemia in Morocco
    Mariame El Messal, Karima Aït Chihab, Rachid Chater, Mohamed LOUFTI, Anas Kettani, A. Hafidi, A. Adlouni · 2006 · Acta Cardiologica
  77. Genetic Basis for Diagnosis of Novel Mutation of LDLReceptor Gene
    Samia Perwaiz Khan, Rubina Ghani, Khwaja Zafar Ahmed, Zia Yaqub · 2011 · International journal of collaborative research on internal medicine & public health
  78. Postępowanie w heterozygotycznej hipercholesterolemii rodzinnej. Stanowisko Forum Ekspertów Lipidowych
    Andrzej Rynkiewicz, Barbara Cybulska, Maciej Banach, Krzysztof Jerzy Filipiak, Tomasz Jan Guzik, Barbara Idzior−Waluś, Jacek Imiela, Piotr Jankowski, Longina Kłosiewicz−Latoszek, Janusz Limon et al. · 2013 · Family Medicine & Primary Care Review
  79. Heterozygous Familial Hypercholesterolemia With APOE Haplotype: A Prospective Harbinger of a Catastrophic Cardiovascular Event
    Glenmore U. Lasam, Siddesh Shambhu, Robert D. Fishberg · 2017 · Cardiology Research
  80. Caracterización clínica y molecular en hipercolesterolemia familiar homocigota
    Erika Andrea Rincón, Juan Esteban Gómez‐Mesa, Harry Pachajoa · 2018 · Revista de la Facultad de Medicina
  81. Prevalence of cardiovascular events in genetically confirmed versus unconfirmed familial hypercholesterolaemia
    Tina Z. Khan, Jane B. Breen, Emma Neves, Richard M. Grocott-Mason, Mahmoud Barbir · 2020 · Global Cardiology Science and Practice
  82. Hiperlipidemias: concepto, clasificación y mecanismo etiopatogénico. Hiperlipidemias primarias
    Miguel Pocoví Mieras, Pilar Alonso, Pedro Gómez · 2004 · Medicine - Programa de Formación Médica Continuada Acreditado
  83. Lipoprotein apheresis in the management of severe hypercholesterolemia and hyperlipoproteinemia(a)—The Portuguese experience
    Lia Ferreira, Isabel Palma, Conceição Bacelar, José Alexandre Queirós, Anselmo Madureira, José Carlos Oliveira, Maria Helena Ramos, Helena Cardoso · 2018 · Transfusion and Apheresis Science
  84. Low density lipoprotein receptor (LDLR) gene and ocular manifestation in Malay patients with familial hypercholesterolaemia
    Ahmad Tajudin Liza-Sharmini, Nor Idahriani Muhammad Nur, Nor Idahriani Muhammad Nur, Alyaa Al-Khateeb, Wan Hazabbah Wan Hitam, Zilfalil Alwi · 2019 · Malaysian Journal of Ophthalmology
  85. Perfil de risco cardiovascular em amostras de estudantes do ensino secundário da região de Lisboa
    Teresa Maria Rodrigues Rocha · 2010 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  86. Cardiovascular disease risk in patients with elevated LDL-C levels: FH vs. non-FH
    Haomin Huang, Lamei Li, Anni Yang, Tao Chen, Ganwei Shi, Feng Li, Luya Wang, Gaojun Cai · 2024 · Frontiers in Cardiovascular Medicine
  87. Clínica y genética de la hipercolesterolemia familiar en Mallorca
    Emilia Mateu, Marina Colom · 2009 · Biblioteca Digital de les Illes Balears (Universitat de les Illes Balears)
  88. Manejo de las dislipemias en poblaciones especiales: formas primarias, infancia y adolescencia
    P. Mata, Rodrigo Alonso K, Nelva Mata · 2005 · Atención Primaria
  89. Clinical Guidelines on Hyperlipidaemia: Recent Developments, Future Challenges and the Need for an Australian Review
    DAVID R. SULLIVAN, Gerald Francis Watts, Stephen James Nicholls, Philip J. Barter, Robert D Grenfell, Clara Kayei Chow, Andrew Maxwell Tonkin, ANTHONY C. KEECH · 2014 · Heart Lung and Circulation
  90. Las concentraciones de Apo-B100 en los pacientes con hipercolesterolemia familiar se asocian a una mayor rigidez arterial
    Núria Plana, Daiana Ibarretxe, Raimón Ferré, Jordi Merino, Josefa Girona, Mercedes Heras, L. Masana · 2012 · Clínica e Investigación en Arteriosclerosis
  91. A Case of Severe Carotid Stenosis in a Patient with Familial Hypercholesterolemia without Significant Coronary Artery Disease
    Marcos Aurélio Lima Barros, Hygor Ferreira-Fernandes, Ingrid Cristina Rêgo Barros, Adriel Rêgo Barbosa, Giovanny Rebouças Pinto · 2014 · Case Reports in Cardiology
  92. Eficacia y seguridad de ezetimiba en unidades de riesgo vascular
    José Luis Díaz-Díaz, Manuel Suárez Tembra, José Antonio Díaz Peromingo, Marta Pena Seijo, Teresa Martínez Ramonde, Antonio Pose Reino · 2011 · Revista Clínica Española
  93. New therapies for familial hypercholesterolemia
    John R. Burnett, Gerald Francis Watts · 2006 · Expert Opinion on Therapeutic Patents
  94. Hypercholesterolaemia in children and young adults—current management
    Frederick Johan Raal · 2008 · South African Family Practice
  95. Severe coronary artery disease in premenopausal woman with familial hypercholesterolaemia
    Nikolina Roszczyk, Karina A. Wierzbowska-Drabik, Radosław Kręcki, Jarosław Damian Kasprzak · 2013 · Kardiologia Polska
  96. Mutación en el gen de apolipoproteína B responsable de hipercolesterolemia familiar: primeros dos casos clínicos reportados en Uruguay
    Patricia Esperón, Víctor E. Raggio, Mariana Lorenzo, Mario Stoll · 2013 · Redalyc (Universidad Autónoma del Estado de México)
  97. Genetic Disorders of Lipoprotein Metabolism
    Alan S. Brown, Ehab G. Dababneh, Adib M. Chaus, Vadzim Chyzhyk, Victor Marinescu, Nataliya Pyslar · 2020 · Contemporary cardiology
  98. Familial Hypercholesterolemia: Improving Outcomes with Newer Agents
    Saumitra Ray, Biswarup Sarkar · 2020 · American Journal of Internal Medicine
  99. DYSLIPIDEMIAS
    Matthew S. Murphy, Timothy O’Brien · 2009 · Elsevier eBooks
  100. Effect of Diet on Lipid Levels in Children/Adolescents with Familial Hypercholesterolemia
    K Widhalm, Karin Fallmann · 2022 · Austin Journal of Nutrition and Food sciences